Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CLEOCIN 100 MG VAGINAL OVULE

clindamycin phosphate
$60.2150per EA

Strength

100 mg/1

Manufacturer

Pharmacia & Upjohn Company LLC

NDC

00009766705

Classification

Brand

Dosage Form

SUPPOSITORY

Route

VAGINAL

Last Updated

1/1/2026

Active Ingredients

CLINDAMYCIN PHOSPHATE

Approval Type

New Drug (NDA)

FDA Application

NDA050767

On Market Since

8/13/1999

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.5%

1Y

+2.5%

3Y

N/A

5Y

N/A

All

+2.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

E.E.S. 200 MG/5 ML GRANULES
Brand
24338013610•Azurity Pharmaceuticals Inc.
$3.1656
per ML
ERYPED 200 MG/5 ML SUSPENSION
Brand
24338013213•Azurity Pharmaceuticals Inc.
$3.6046
per ML
E.E.S. 200 MG/5 ML SUSPENSION
Brand
24338013402•Azurity Pharmaceuticals Inc.
$3.6046
per ML
E.E.S. 200 MG/5 ML SUSPENSION
Brand
80005015218•Carnegie Pharmaceuticals LLC
$3.6046
per ML
ERYPED 400 MG/5 ML SUSPENSION
Brand
24338013013•Azurity Pharmaceuticals Inc.
$6.3072
per ML
ERYPED 400 MG/5 ML SUSPENSION
Brand
80005015518•Carnegie Pharmaceuticals LLC
$6.3072
per ML
FINACEA 15% FOAM
Brand
50222030350•LEO Pharma Inc.
$8.3262
per GM
ACANYA GEL PUMP
Brand
13548013250•Bausch Health US LLC
$10.1746
per GM
ZIANA GEL
Brand
99207030060•Bausch Health US LLC
$11.4072
per GM
ZIANA GEL
Brand
99207030030•Bausch Health US LLC
$11.7846
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy